References

Unresolved reference

1993 · External reference

Current thyroid cancer trends in the united states

10.1001/jamaoto.2014.1 · 2014 · External reference

Cancer statistics

2015 · External reference

Unresolved reference

2015 · External reference

Cancer statistics, 2009

2009 · External reference

Long-term risks for thyroid cancer and other neoplasms after exposure to radiation

10.1038/ncpendmet0022 · 2005 · External reference

Unresolved reference

2010 · External reference

The role of external beam radiation and targeted therapy in thyroid cancer

10.1016/j.semradonc.2012.03.010 · 2012 · External reference

Thyroid carcinoma

10.1016/s0140-6736(03)12488-9 · 2003 · External reference

Revised American Thyroid Association Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

10.1089/thy.2009.0110 · 2009 · External reference

Revised American Thyroid Association Guidelines for the management of medullary thyroid carcinoma

10.1089/thy.2014.0335 · 2015 · External reference

American Thyroid Association Guidelines for management of patients with anaplastic thyroid cancer

10.1089/thy.2012.0302 · 2012 · External reference

Cd133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy

10.1007/s00259-012-2242-5 · 2013 · External reference

Patterns of relapse following radiotherapy for differentiated thyroid cancer: Implication for target volume delineation

10.1016/j.radonc.2008.05.023 · 2008 · External reference

Results of postoperative radiation therapy in medullary carcinoma of the thyroid: A retrospective study by the french federation of cancer institutes–the radiotherapy cooperative group

10.1016/0167-8140(92)90298-9 · 1992 · External reference

Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: Analysis of the surveillance, epidemiology, and end results 1983-2002

10.1097/coc.0b013e31816a61f3 · 2008 · External reference

Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies

10.1016/j.clon.2010.03.013 · 2010 · External reference

Fast neutron radiotherapy: Where have we been and where are we going? The jury is still out–regarding Maor et al., IJROBP 1995;32:599-604

10.1016/0360-3016(95)00185-2 · 1995 · External reference

Biological factors influencing the rbe of neutrons: Implications for their past, present and future use in radiotherapy

10.1667/0033-7587(2001)156[0125:bfitro]2.0.co;2 · 2001 · External reference

Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands

10.1002/hed.10027 · 2001 · External reference

Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy

10.1016/s0360-3016(99)00445-9 · 2000 · External reference

Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands

10.1016/s0360-3016(96)00213-1 · 1996 · External reference

Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors

10.1002/(sici)1097-0347(199905)21:3<255::aid-hed11>3.0.co;2-2 · 1999 · External reference

Neutron radiotherapy for adenoid cystic carcinoma of the lacrimal gland

10.1097/iop.0b013e318295f99b · 2013 · External reference

Neutron vs photon irradiation of inoperable salivary gland tumors: Results of an RTOG-MRC cooperative randomized study

10.1016/0360-3016(88)90188-5 · 1988 · External reference

Fast neutron radiotherapy for sarcomas of soft tissue, bone, and cartilage

10.1097/00000421-198908000-00009 · 1989 · External reference

Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council

10.1016/0360-3016(93)90233-l · 1993 · External reference

Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy

10.1002/hed.21257 · 2010 · External reference

Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays

10.1016/0014-2964(81)90056-6 · 1981 · External reference

High energy (42-66 mev reactions) fast neutron dose optimization studies in the head and neck, thorax, upper abdomen, pelvis and extremities

10.1016/0167-8140(90)90030-z · 1990 · External reference

Fast-neutron therapy in advanced head and neck cancer: A collaborative international randomized trial

10.1016/0360-3016(94)00595-c · 1995 · External reference

Unilateral total lobectomy: Is it sufficient surgical treatment for patients with ames low-risk papillary thyroid carcinoma?

10.1016/s0039-6060(98)70035-2 · 1998 · External reference

Low-risk differentiated thyroid cancer: The need for selective treatment

10.1007/bf02303583 · 1997 · External reference

Extent of surgery affects survival for papillary thyroid cancer

10.1097/sla.0b013e31814697d9 · 2007 · External reference

Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years

10.1111/j.1365-2265.2005.02358.x · 2005 · External reference

Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pt4)

10.1002/(sici)1097-0142(19960101)77:1<172::aid-cncr28>3.0.co;2-1 · 1996 · External reference

Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy

10.1016/s0360-3016(01)02686-4 · 2002 · External reference

Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients

10.1016/0360-3016(88)90381-1 · 1988 · External reference

Adjuvant external beam radiation for medullary thyroid carcinoma

10.1002/jso.21557 · 2010 · External reference

Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control

10.1089/thy.1996.6.305 · 1996 · External reference

A role for radiotherapy in the management of advanced medullary thyroid carcinoma: The Mayo Clinic experience

10.4081/rt.2013.e37 · 2013 · External reference

Postoperative radiotherapy for advanced medullary thyroid cancer–local disease control in the modern era

10.1002/hed.20791 · 2008 · External reference

Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens

10.1002/cncr.22203 · 2006 · External reference

Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy

10.1016/j.ijrobp.2004.05.032 · 2004 · External reference

Multicenter study differentiated thyroid carcinoma (msds). Diminished acceptance of adjuvant external beam radiotherapy

10.1055/s-0038-1625735 · 2003 · External reference

Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid

10.1089/thy.2012.0103 · 2013 · External reference

A phase II study of imatinib in patients with advanced anaplastic thyroid cancer

10.1089/thy.2010.0057 · 2010 · External reference

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study

10.1200/jco.2007.15.9566 · 2008 · External reference

Braf inhibition in brafv600e-positive anaplastic thyroid carcinoma

10.6004/jnccn.2016.0030 · 2016 · External reference